Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast

Journal of Allergy and Clinical Immunology

Volumn 106, Issue 6, 2000, Pages 1088-1095

  Nelson, Harold S ^a   Busse, William W ^b   Kerwin, Edward ^c   Church, Nina ^d   Emmett, Amanda ^d   Rickard, Kathleen ^d   Knobil, Katharine ^d  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c Clinical Research Institute of Southern Oregon PC   (United States)

^d GLAXOSMITHKLINE   (United States)

Author keywords

Advair; Asthma; Combination therapy; Fluticasone propionate; Leukotriene modifiers; Montelukast; Salmeterol; Seretide

Indexed keywords

FLUTICASONE PROPIONATE; MONTELUKAST; SALMETEROL;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEADACHE; HERNIA STRANGULATION; HOARSENESS; HUMAN; INGUINAL HERNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; SORE THROAT; THRUSH;

EID: 0034538067     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2000.110920     Document Type: Article

References (40)

1. Diskus and Diskhaler: Efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma
2. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma
3. A study on the clinical equivalence and patient preference of fluticasone propionate 250 microg twice daily via the Diskus/Accuhaler inhaler or the Diskhaler inhaler in adult asthmatic patients
4. Fluticasone propionate powder: Oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma
5. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid
6. Comparison of the addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids
7. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma
8. The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma
9. Salmeterol added to inhaled corticosteroid therapy is superior to doubling the dose of inhaled corticosteroids: A randomized clinical trial
10. Concurrent use of salmeterol with inhaled corticosteroids is more effective than inhaled corticosteroid dose increases
11. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: As effective as when given via separate Diskus inhalers
12. Salmeterol/fluticasone propionate (50/500microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma
13. Combined salmeterol 50mg and fluticasone propionate 250mg in the Diskus device for the treatment of asthma
14. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled trial
15. Effects of leukotrienes in the treatment of asthma
16. Alternative agents for anti-inflammatory treatment of asthma
17. The role of leukotrienes in inflammation
18. Leukotriene pathway inhibitors in asthma and chronic obstructive pulmonary disease
19. Randomized, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients
20. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma
21. Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma
22. Montelukast added to inhaled beclomethasone in treatment of asthma
23. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma
24. Reference spirometric values using techniques and equipment that meets ATS recommendations
25. Symptoms perception in asthma: A multidisciplinary review
26. Relation of the perception of airway obstruction to the severity of asthma
27. What are minimal important changes for asthma measures in a clinical trial?
28. Effect of inhaled formoterol and budesonide on exacerbations of asthma
29. The combination of salmeterol and low-dose fluticasone versus higher-dose fluticasone: An analysis of asthma exacerbations
30. Exacerbations of asthma: A descriptive study of 425 severe exacerbations. The FACET International Study Group
31. Asthma control during long term treatment with regular inhaled salbutamol and salmeterol
32. Mete-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA)
33. Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma
34. Inhaled salmeterol and fluticasone: A study comparing monotherapy and combination therapy in asthma
35. Fluticasone alone or in combination with salmeterol vs triamcinolone acetonide in asthma
36. Comparison of patient's compliance with prescribed oral and inhaled asthma medications
37. Effect of salmeterol on patient's adherence to their prescribed refills for inhaled corticosteroids
38. Asthma controller medications: What do patients want?